This page lists all known medications that could potentially lead to 'Abnormal Erythropoiesis' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

THE anemia of renal insufficiency is associated with both increased red-cell destruction and impaired erythropoietic response to anemia. Variations in the relative importance of these 2 mechanisms and ...

Background: Erythropoiesis-stimulating agents are used to treat anemia in patients with cancer. However, their safety and effectiveness is controversial. We did a systematic review of the clinical ...

Although erythropoietin (Epo) is commonly used as a therapy for anemia, recent studies have suggested that Epo therapy is associated with adverse outcomes. A new study shows that polymeric IgA1 ...

Anemia in patients with cancer can be caused by a number of factors including blood loss, hemolysis, nutritional deficiencies, renal insufficiency, marrow infiltration, anemia of chronic disease and ...

Two hundred-billion red blood cells are renewed in our body every single day. These erythrocytes (also known as red blood cells) are generated from bi-potent megakaryocyte-erythroid progenitor cells ...

THE administration of androgenic hormones to women with advanced breast cancer has been associated with an unusual alteration in erythropoietic activity. 1–10 This has consisted of increases in ...

Erythropoietin (EPO) is a hormone predominantly produced in the kidney, which is then released into blood. Erythropoietin promotes the production of red blood cells (erythropoiesis) in the bone marrow ...

The State of Cancer Care in America, 2015: A Report by the American Society of Clinical Oncology Medicare Part D prescription benefits cover injected medications, normally covered under Part B, when ...

Please provide your email address to receive an email when new articles are posted on . In 1989, epoetin alfa was approved by the FDA to treat anemia resulting from chronic kidney disease. Epoetin ...